Showing results (131-140 of 589) with videos related to
Sort By:
Pageof 59
Journal of Cancer Research and Clinical Oncology|January 18, 2023
Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanomaJose Lutzky, Ryan J Sullivan, Justine V Cohen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2021
Immune Checkpoint Inhibition in Marjolin Ulcer: A Case SeriesSophia Z Shalhout, Howard L Kaufman, Ryan J Sullivan, et al.Journal of the American Academy of Dermatology|December 26, 2025
Updates in Adjuvant and Neoadjuvant Therapies for Resectable Cutaneous MelanomaMatthew J Hadfield, Sonal Muzumdar, Ryan J Sullivan, et al.American Journal of Hematology|February 9, 2008
HIV-associated multicentric Castleman's diseaseJustin Stebbing, Liron Pantanowitz, Farshid Dayyani, et al.Seminars in Oncology|August 31, 2015
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With ImmunotherapyJennifer A Wargo, Alexandre Reuben, Zachary A Cooper, et al.Acta Neuropathologica Communications|March 13, 2025
Collision tumor, a metastatic melanoma within a meningioma: a case reportErika Yamazawa, Daniel P Cahill, Matthew P Frosch, et al.Therapeutic Advances in Medical Oncology|June 18, 2019
Management of metastatic cutaneous melanoma: updates in clinical practiceGustavo Schvartsman, Patricia Taranto, Isabella C Glitza, et al.Melanoma Management|September 8, 2018
Bowel perforation associated with robust response to BRAF/MEK inhibitor therapy for BRAF-mutant melanoma: a case reportSamantha L Kass, Allison F Linden, Patrick G Jackson, et al.Future Oncology (London, England)|April 20, 2022
Real-world treatment patterns and overall survival in BRAF-mutant melanoma patients treated with immunotherapy or targeted therapyMichael B Atkins, Cristina Julian, Matthew H Secrest, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
Liver biopsy findings in patients on immune checkpoint inhibitorsJustine V Cohen, Michael Dougan, Leyre Zubiri, et al.Pageof 59